From FDA reports: drug interactions between Repronex 75 Iu Fsh; 75 Iu Lh, Lupron Microdose Sq, Bravelle
This is a study of Repronex 75 Iu Fsh; 75 Iu Lh, Lupron Microdose Sq, Bravelle drug interactions. The study is created by eHealthMe based on reports of 19 people who take the same drugs and have drug interactionsfrom FDA.
Get a free personalized report of your drugs: we study for you 352 million drug outcomes from FDA and social media. Start to use eHealthMe >>>
On Sep, 13, 2014: 19 people who reported to have interactions when taking Repronex 75 Iu Fsh; 75 Iu Lh, Lupron Microdose Sq, Bravelle are studied
Information of the patient in this study:
Conditions: Infertility Female
- Repronex 75 Iu Fsh; 75 Iu Lh: used for < 1 month
- Lupron Microdose Sq
Drug interactions have: Injection Site Cellulitis, Injection Site Erythema, Injection Site Swelling, Pain, Pharmaceutical Product Complaint
eHealthMe real world results:
For people in general (regardless of gender or age):
Comparison with this patient's adverse outcomes:
|Interaction||Number of reports|
|Injection Site Cellulitis (injection site inflammation)||2 (10.53%)|
|Injection Site Erythema (redness at injection site)||2 (10.53%)|
|Injection Site Swelling||2 (10.53%)|
|Pharmaceutical Product Complaint||2 (10.53%)|
Most common interactions experienced by people in the use of Repronex 75 Iu Fsh; 75 Iu Lh, Lupron Microdose Sq, Bravelle:
|Interaction||Number of reports|
|Ovarian Hyperstimulation Syndrome (excess egg stimulation from ovary due to medicine)||12|
|Dyspnoea (difficult or laboured respiration)||8|
|Headache (pain in head)||8|
|Subclavian Vein Thrombosis (abnormal condition in which a clot develops within the subclavian or axillary vein)||6|
|Jugular Vein Thrombosis (clot in jugular vein)||6|
|Blood Sodium Decreased||6|
|Local Swelling (swelling at the site of some application of substance or injury)||4|
Most common interactions experienced by people in long term use of Repronex 75 Iu Fsh; 75 Iu Lh, Lupron Microdose Sq, Bravelle:
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
You can also:
- Subscribe the study: get notified of updates
- Post a comment: or see what other people said about the study
- Join a mobile peer support group:
- group for people who take Bravelle and have Pain
NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.